Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
martes, noviembre 03
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Cencora Inc
COR
NYSE
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$337.84
7.00
2.12%
Últ. Act.: Nov 2, 4:00 PM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Dividendos
Comparar
Opciones
Informe de acciones
Ganancias:
Los beneficios de Q4 2026 mañana en mié nov 4th antes de la apertura del mercado
Conferencia telefónica:
Conferencia telefónica programada para mañana a las 8:30 a. m.
Haz clic para ver el webcast
Cencora Financials
Cencora (COR) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Cencora Says Certain Walgreens Volume Moves Outside Cencora From July 1, 2026; Reaffirms FY26 Adj Diluted EPS Guidance Range Of $17.75-$17.95; Says Prime Vendor Agreement With Walgreens Remains Unchanged
Beginning July 1, 2026, certain Walgreens volume that was being serviced by Cencora, Inc. (the "Company" or "Cencora") separate from the prime vendor agreement began moving outside the Company. The prime
Benzinga Newsdesk
Cencora Sees Specialty Growth Continue While GLP-1 Mix Weighs on Margins
Cencora beats third-quarter earnings and revenue estimates, raised fiscal 2026 EPS guidance and maintains its annual sales forecast.
Vandana Singh
PRO
Cencora Raises FY2026 Adj EPS Guidance from $17.70-$17.90 to $17.75-$17.95 vs $17.79 Est; Affirms FY2026 Sales Guidance of $334.152B-$340.578B vs $337.203B Est
Cencora (NYSE:COR) raises FY2026 Adj EPS guidance from $17.70-$17.90 to $17.75-$17.95 vs $17.79 analyst estimate. Affirms FY2026 sales outlook from $334.152 billion-$340.578 billion to $334.152 billion-$340.578 billion
Benzinga Newsdesk
PRO
Cencora Q3 Adj. EPS $4.48 Beats $4.35 Estimate, Sales $84.754B Beat $84.315B Estimate
Cencora (NYSE:COR) reported quarterly earnings of $4.48 per share which beat the analyst consensus estimate of $4.35 by 2.99 percent. This is a 12 percent increase over earnings of $4.00 per share from the same period
Benzinga Newsdesk
Earnings Scheduled For May 6, 2026
Benzinga Insights
Why Is Cencora Stock Trading Lower On Wednesday?
Cencora stock falls after Q2 earnings miss and lower sales guidance, despite raising EPS outlook and reporting mixed segment growth.
Vandana Singh
